M 1 (Methotrexate 2.5 mg)
Pill imprint M 1 has been identified as Methotrexate sodium 2.5 mg.
Methotrexate is used in the treatment of rheumatoid arthritis; psoriatic arthritis; ectopic pregnancy; psoriasis; dermatomyositis (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M 1
- Strength:
- 2.5 mg
- Color:
- Yellow
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- DAVA Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 67253-0320
- Inactive Ingredients:
- lactose
magnesium stearate
corn starch
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67253-0580 | DAVA Pharmaceuticals, Inc. |
Note: Inactive ingredients may vary.
More about methotrexate
Consumer resources
- Methotrexate
- Methotrexate tablets
- Methotrexate injection
- Methotrexate (Advanced Reading)
- Methotrexate Oral, Injection (Advanced Reading)
- Other brands: Trexall, Rasuvo, Rheumatrex Dose Pack, Otrexup
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
